King Luther Capital Management Corp bought a new position in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 33,691 shares of the company's stock, valued at approximately $4,223,000. King Luther Capital Management Corp owned about 0.19% of Addus HomeCare at the end of the most recent reporting period.
Other hedge funds also recently bought and sold shares of the company. Farther Finance Advisors LLC increased its holdings in Addus HomeCare by 9,150.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company's stock valued at $49,000 after buying an additional 366 shares during the period. Janney Montgomery Scott LLC raised its holdings in shares of Addus HomeCare by 2.3% in the 3rd quarter. Janney Montgomery Scott LLC now owns 10,600 shares of the company's stock worth $1,410,000 after buying an additional 234 shares in the last quarter. Assetmark Inc. lifted its position in shares of Addus HomeCare by 11.5% during the 3rd quarter. Assetmark Inc. now owns 1,169 shares of the company's stock worth $156,000 after buying an additional 121 shares during the period. Crossmark Global Holdings Inc. bought a new stake in Addus HomeCare in the third quarter valued at $228,000. Finally, Los Angeles Capital Management LLC raised its stake in Addus HomeCare by 32.6% during the third quarter. Los Angeles Capital Management LLC now owns 11,711 shares of the company's stock worth $1,558,000 after acquiring an additional 2,879 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors.
Several research firms have recently weighed in on ADUS. StockNews.com lowered shares of Addus HomeCare from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th. Citizens Jmp raised shares of Addus HomeCare to a "strong-buy" rating in a report on Monday, December 16th. Royal Bank of Canada reissued an "outperform" rating and issued a $136.00 target price on shares of Addus HomeCare in a report on Thursday, November 14th. Stephens reaffirmed an "overweight" rating and set a $142.00 price target on shares of Addus HomeCare in a report on Wednesday. Finally, JMP Securities started coverage on Addus HomeCare in a research note on Monday, December 16th. They issued an "outperform" rating and a $150.00 price objective on the stock. One research analyst has rated the stock with a sell rating, one has issued a hold rating, seven have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $132.78.
Get Our Latest Analysis on Addus HomeCare
Addus HomeCare stock traded down $2.31 during trading hours on Thursday, reaching $90.78. 150,935 shares of the company's stock traded hands, compared to its average volume of 146,790. Addus HomeCare Co. has a fifty-two week low of $87.88 and a fifty-two week high of $136.72. The firm's 50 day moving average is $116.65 and its 200-day moving average is $123.82. The firm has a market capitalization of $1.65 billion, a price-to-earnings ratio of 20.77, a PEG ratio of 1.41 and a beta of 0.97.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings data on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). The business had revenue of $297.14 million during the quarter, compared to the consensus estimate of $291.04 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. Analysts predict that Addus HomeCare Co. will post 4.59 EPS for the current year.
In other Addus HomeCare news, CEO R Dirk Allison sold 25,000 shares of the firm's stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the transaction, the chief executive officer now owns 79,397 shares in the company, valued at approximately $9,905,569.72. This trade represents a 23.95 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 4.60% of the stock is owned by insiders.
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.